Evidence map›Paper›PMID 35460293›Full record

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2022

Reduced AIBP expression in bronchial epithelial cells of asthmatic patients: Potential therapeutic target.

Marina Miller, Alexa K Pham, Ayelet Gonen, Juliana M Navia-Pelaez, Katherine Xia, Sungwoo Park, Andrei L Osterman, Kevin Bacon, Graham Beaton, Richard C Kurten and 2 more

Open access · greenAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Marina MillerDivision of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Alexa K PhamDivision of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Ayelet GonenDivision of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Juliana M Navia-PelaezDivision of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Katherine XiaDivision of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, La Jolla, California, USA.
Sungwoo ParkRaft Pharmaceuticals LLC, San Diego, California, USA.
Andrei L OstermanSanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Kevin BaconRaft Pharmaceuticals LLC, San Diego, California, USA.
Graham BeatonRaft Pharmaceuticals LLC, San Diego, California, USA.
Richard C KurtenDepartment of Pediatrics, Arkansas Children's Research Institute, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
David H BroideDivision of Rheumatology, Allergy and Immunology, Department of Medicine, University of California, San Diego, La Jolla, California, USA.ORCID 0000-0001-8405-9090
Yury I MillerDivision of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA.ORCID 0000-0003-0521-7690
La Jolla Institute for Immunology · USTracon Pharmaceuticals (United States) · USUniversity of California San Diego · USArkansas Children's Hospital · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

TRM and airway inflammation and remodelingU19AI070535 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROIDE, DAVID H · 2006 to 2025
$34.2M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
AIBP therapyR35HL135737 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILLER, YURY · 2017 to 2023
$6.5M
Chromosome 17q, allergic inflammation, and remodelingR01AI107779 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROIDE, DAVID H · 2013 to 2024
$4.7M
GSDMB and mucosal allergic responseR01AI124236 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BROIDE, DAVID H · 2017 to 2020
$2.4M
Targeting lipid rafts for treatment of asthmaR41AI147879 · NIAID · RAFT PHARMACEUTICALS, LLC · PI BACON, KEVIN, BROIDE, DAVID H · 2019 to 2020
$600k
NHLBI NIH HHS R35 HL135737NIAID NIH HHS R01 AI107779NIAID NIH HHS R01 AI124236NIAID NIH HHS R41 AI147879NIAID NIH HHS U19 AI070535NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AsthmaBronchial HyperreactivityBronchiEpithelial CellsHumansairway hyperresponsivenessapolipoprotein A-I binding proteinasthmabronchial epitheliumeosinophilinflammation

Identifiers

PMID35460293
PMCPMC10241564
OpenAlexW4224326823

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.